Cytori Scleroderma Trial Data Presented at Systemic Sclerosis World Congress
Feb 15, 2018 13:01 pm UTC| Business
SAN DIEGO, Feb. 15, 2018 -- Cytori Therapeutics, Inc. (Nasdaq:CYTX) (“Cytori” or “the Company”) today presented data from the U.S. 88 patient, 19 center, randomized, double blind, placebo-controlled STAR clinical trial...
Genocea Reports Fourth Quarter and Full-Year 2017 Financial Results
Feb 15, 2018 13:01 pm UTC| Business
- GEN-009 neoantigen vaccine advancing to IND filing - - Balance sheet strengthened with $55m gross proceeds from January equity financing - - Conference call today at 9 am ET - CAMBRIDGE, Mass., Feb. 15, 2018 --...
Feb 15, 2018 13:01 pm UTC| Business
NEW YORK, Feb. 15, 2018 -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI) a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today announced that Sharon...
Hands-Free Farm Mission Featured at National Farm Machinery Show
Feb 15, 2018 13:01 pm UTC| Business
Louisville, KY, Feb. 15, 2018 -- The Hands-Free Farm™ movement, developed by Outback Guidance, a brand of AgJunction, Inc. (TSX: AJX), made a major impact at the National Farm Machinery Show in Louisville, Kentucky,...
Amfil Technologies Inc. Announces Fiscal Q2 2018 Revenues Up 114% Year Over Year to $3,307,549
Feb 15, 2018 13:01 pm UTC| Business
Toronto, ON, Feb. 15, 2018 -- Amfil Technologies Inc. (OTC: AMFE) is pleased to provide our shareholders with a summary of our Fiscal Q2 2018 Financials. Revenues were up over 114% fiscal year over year from...
Progressive Care to Accept Bitcoin for its Pharmacy Unit
Feb 15, 2018 13:01 pm UTC| Business
MIAMI, Feb. 15, 2018 -- Progressive Care Inc. (OTCQB:RXMD), a healthcare services and technology company, announces that its retail pharmacy will officially begin accepting Bitcoin payments. Customers that choose to pay...
Athenex Meets Enrollment Target for Oraxol Phase III Clinical Trial in Metastatic Breast Cancer
Feb 15, 2018 13:01 pm UTC| Business
BUFFALO, N.Y., Feb. 15, 2018 -- Athenex (Nasdaq:ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer and related...